BCBetania Barros Cota

Betania Barros Cota

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Betania Barros Cota has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Two new usnic acid derivatives from the endophytic fungus Mycosphaerella sp.

    by Djalma M. de Oliveira, Cristiane B. Pereira, Graziele Mendes, Jochen Junker, Markus Kolloff, Luiz H. Rosa, Carlos A. Rosa, Tânia M.A. Alves, Carlos L. Zani, Susana Johann, et al.

    The endophytic fungus Mycosphaerella sp. (UFMGCB2032) was isolated from the healthy leaves of Eugenia bimarginata, a plant from the Brazilian savanna. Two novel usnic acid derivatives, mycousfuranine (1) and mycousnicdiol (2), were isolated from the ethyl acetate extract, and their structure was elucidated by NMR and MS analyses. Compounds 1 and 2 exhibited moderate antifungal activities against Cryptococcus neoformans and Cryptococcus gattii, each with minimum inhibitory concentration values of 50.0 μg/mL and 250.0 μg/mL, respectively.


  • In vitro leishmanicidal, antibacterial and antitumour potential of anhydrocochlioquinone A obtained from the fungus Cochliobolus sp.

    by Fernanda F Campos, Jonas P Ramos, Djalma M De Oliveira, Tânia M A Alves, Elaine M De Souza-Fagundes, Carlos L Zani, Fábio C Sampaio, Attilio Converti, Betania B Cota

    The bioassay-guided fractionation of the ethyl acetate extract of the fungus Cochliobolus sp. highlighted leishmanicidal activity and allowed for anhydrocochlioquinone A (ANDC-A) isolation. MS, 1D and 2D NMR spectra of this compound were in agreement with those published in the literature. ANDC-A exhibited leishmanicidal activity with EC50 value of 22.4 µg/mL (44 μM) and, when submitted to the microdilution assay against Gram-positive and Gram-negative bacteria, showed a minimal inhibitory concentration against Staphylococcus aureus ATCC 25295 of 128 μg/mL (248.7 μM). It was also active against five human cancer cell lines, showing IC50 values from 5.4 to 20.3 μM. ANDC-A demonstrated a differential selectivity for HL-60 (SI 5.5) and THP-1 (SI 4.3) cell lines in comparison with Vero cells and was more selective than cisplatin and doxorubicin against MCF-7 cell line in comparison with human peripheral blood mononuclear cells. ANDC-A was able to eradicate clonogenic tumour cells at concentrations of 20 and 50 μM and induced apoptosis in all tumour cell lines at 20 μM. These results suggest that ANDC-A might be used as a biochemical tool in the study of tumour cells biochemistry as well as an anticancer agent with durable effects on tumours.


  • Open Access

    Bioactive endophytic fungi isolated from Caesalpinia echinata Lam. (Brazilwood) and identification of beauvericin as a trypanocidal metabolite from Fusarium sp.

    by Fernanda Fraga Campos, Policarpo A Sales Junior, Alvaro José Romanha, Márcio Ss Araújo, Ezequias P Siqueira, Jarbas M Resende, Tânia Ma Alves, Olindo A Martins-Filho, Vera Lúcia dos Santos, Carlos A Rosa, et al.

    Aiming to identify new sources of bioactive secondary metabolites, we isolated 82 endophytic fungi from stems and barks of the native Brazilian tree Caesalpinia echinata Lam. (Fabaceae). We tested their ethyl acetate extracts in several in vitro assays. The organic extracts from three isolates showed antibacterial activity against Staphylococcus aureus and Escherichia coli [minimal inhibitory concentration (MIC) 32-64 μg/mL]. One isolate inhibited the growth of Salmonella typhimurium (MIC 64 μg/mL) and two isolates inhibited the growth of Klebsiella oxytoca (MIC 64 μg/mL), Candida albicans and Candida tropicalis (MIC 64-128 μg/mL). Fourteen extracts at a concentration of 20 μg/mL showed antitumour activities against human breast cancer and human renal cancer cells, while two isolates showed anti-tumour activities against human melanoma cancer cells. Six extracts were able to reduce the proliferation of human peripheral blood mononuclear cells, indicating some degree of selective toxicity. Four isolates were able to inhibit Leishmania (Leishmania) amazonensis and one isolate inhibited Trypanosoma cruzi by at least 40% at 20 μg/mL. The trypanocidal extract obtained from Fusarium sp. [KF611679] culture was subjected to bioguided fractionation, which revealed beauvericin as the compound responsible for the observed toxicity of Fusarium sp. to T. cruzi. This depsipeptide showed a half maximal inhibitory concentration of 1.9 μg/mL (2.43 μM) in a T. cruzi cellular culture assay.


    • 1 January 2013
      • Vol. 7  (1) , 26-56

    Anti-allergic potential of herbs and herbal natural products - activities and patents.

    by Betania B Cota, Caryne M Bertollo, Djalma M De Oliveira

    The increase of allergic diseases has accompanied the global population growth and the major challenge is to reduce morbidity. The currently available treatments present limitations regarding efficacy and safety. Hence, patients with chronic allergic conditions seek alternatives to achieve better control of symptoms. Many natural products have been identified as potential anti-allergic agents. In addition, plant formulations have demonstrated, in general, to be safe in clinical trials and demonstrate additional effects along with Western medicines such as synergism and modulation of the immune system. It is known that plants represent a source of new therapeutic agents and some of them have shown mechanisms of action similar to synthetic agents. However, in general, herbs and their combination are patented mainly by Asian countries to be used in food and drinks or cosmetics and dietary supplements and the anti-allergic mechanisms of action are not yet fully elucidated. In this review, we highlight relevant patent and studies with cultivated plants, plant formulations, and secondary metabolites that have been evaluated with respect to its anti-allergic potential.


  • Open Access

    Chemical constituents and leishmanicidal activity from leaves of Kielmeyera variabilis

    by Betania B. Cota, Ezequias P. Siqueira, Djalma M. de Oliveira, Tânia M. A. Alves, Marcos E. G. Sobral, Ana Rabello, Carlos L. Zani


  • New cassane diterpenes from Caesalpinia echinata

    by Betania Barros Cota, Djalma Menezes de Oliveira, Ezequias Pessoa de Siqueira, Elaine Maria Souza-Fagundes, Adriano M.C. Pimenta, Daniel M. Santos, Ana Rabello, Carlos Leomar Zani


  • Open Access

    Antifungal activity of schinol and a new biphenyl compound isolated from Schinus terebinthifolius against the pathogenic fungus Paracoccidioides brasiliensis

    by Susana Johann, Nívea P Sá, Luciana Ars Lima, Patricia S Cisalpino, Betania B Cota, Tânia Ma Alves, Ezequias P Siqueira, Carlos L Zani

    The aim of this study was to isolate and identify the antifungal compounds from the extracts of Schinus terebinthifolius (Anacardiaceae) against clinical isolates of the pathogenic fungus Paracoccidioides brasiliensis.